Retatrutide 10mg User Guide

Welcome to the club. This guide walks you through everything you need to get started — reconstituting, dosing, injecting, and storing your retatrutide. It’s simpler than it looks. Let’s get into it.

You can find this product here: GLP 3 Reta.

---

ABOUT THIS PEPTIDE

Retatrutide is an investigational peptide best known as a “triple agonist” because it activates three related metabolic hormone receptors: GLP-1, GIP, and glucagon. In plain English, it is designed to combine appetite control and blood-sugar signaling from the GLP/GIP side with the added energy-expenditure and fat-mobilization signal associated with glucagon receptor activity.

That triple mechanism is why retatrutide gets so much attention in the weight-loss research world. It is in the same general family as semaglutide and tirzepatide, but it reaches for a stronger metabolic effect by adding the glucagon pathway. The tradeoff is that retatrutide is still newer, still investigational, and does not have the same long-term real-world safety record as approved GLP-1 or GLP-1/GIP medications.

The clinical results so far are unusually strong. In Lilly’s Phase 2 obesity trial, higher-dose retatrutide groups lost up to about 24% of body weight at 48 weeks. In May 2026, Lilly announced topline Phase 3 TRIUMPH-1 results showing average weight loss of about 19% at 4mg, 26% at 9mg, and 28% at 12mg over 80 weeks, with some participants in an extension continuing toward roughly 30% at 104 weeks. Those are sponsor-reported topline results, so they should still be treated differently from fully published peer-reviewed data, but they explain why retatrutide has become one of the most talked-about metabolic research peptides.

Community reports usually line up with the broad trial story: strong weight-loss potential, variable appetite suppression at lower doses, and a need to titrate slowly. Some people describe retatrutide as less immediately appetite-crushing than semaglutide or tirzepatide at the very beginning, then much stronger as the dose climbs. The most common complaints are still gastrointestinal issues like nausea, diarrhea, constipation, reflux, and bloating, with some users also reporting increased resting heart rate, feeling warm or overstimulated, sleep changes, skin sensitivity, or emotional flatness.

The important takeaway is simple: retatrutide looks powerful, but powerful is not the same thing as casual. The evidence base is moving fast, Phase 3 data is now emerging, and the community interest is huge, but it remains an investigational compound with less mature safety data than semaglutide or tirzepatide.

Quick notes:

• Best known for: metabolic and body-composition research.
• Mechanism: GLP-1, GIP, and glucagon receptor agonism.
• Evidence level: strong Phase 2 data, emerging Phase 3 topline data, not FDA-approved.
• Community theme: strong results, slower ramp preferred, side effects can build after dose increases.
• Main watch-out: GI effects, heart-rate changes, overstimulation, and limited long-term safety data.

---

SUPPLIES YOU’LL NEED

• Insulin needles — https://www.amazon.com/dp/B07P2KK5P7
• Alcohol swabs — https://www.amazon.com/dp/B07F2MQ9NJ
• Reconstitution solution (bacteriostatic water) — https://progressionpeptides.com/product/bacteriostatic-water/

---

RECONSTITUTION (MIXING)

Each bottle contains 10mg of retatrutide in powder form. You need to add liquid to it before you can use it.

Here’s what to do:

1. Draw up 100 units of reconstitution solution (that’s 1mL — two full insulin syringes worth, 50 units each).
2. Inject the solution slowly into the retatrutide bottle. Aim the stream at the glass wall, not directly onto the powder.
3. Swirl gently. Don’t shake it. Let it dissolve — may take a minute or two.

That’s it. You now have a bottle where every 1 unit on the syringe = 0.1mg of retatrutide. The math stays clean:

Units on syringe	Retatrutide dose
5 units	0.50 mg
10 units	1.00 mg
15 units	1.50 mg
20 units	2.00 mg
25 units	2.50 mg
40 units	4.00 mg
50 units	5.00 mg
60 units	6.00 mg

---

DOSING SCHEDULE

Start low. Your body needs time to adjust.

• Weeks 1–2: 10 units per week (1.00mg)
• Week 3+: If you feel fine, move up to 20–40 units per week (2.00–4.00mg).
• Stay in the 20–40 unit range for as long as it’s working — months is totally fine.
• If hunger creeps back after a couple months and you want a higher dose, some routines move up to 40–60 units per week (4.00–6.00mg).

That’s it. Just increase gradually until you’re not getting as hungry, and you’re losing weight. The 2–4mg weekly range is a common effective zone, while 4–6mg per week is the higher-dose lane. But if 1mg works for you, why take more.

Stop taking it whenever you want — no tapering needed.

---

HOW TO INJECT

Watch this quick video — it covers everything: https://www.youtube.com/watch?v=e9NGueNM03I

The basics:

1. Wipe the top of the retatrutide bottle with an alcohol swab.
2. Draw your dose into the syringe.
3. Pinch a bit of belly fat (or thigh), insert the needle, and push the plunger slowly.
4. Done. Once a week, same day each week if you can.

---

SIDE EFFECTS

Most people have none.

The most common one, when it happens, is slight nausea for the first week or two. I had that. Just a mild queasy feeling after eating a big meal. Nothing major — it goes away.

Some people get constipated early on. If you’re worried about that, take some fiber for the first couple weeks and you’ll be fine.

With retatrutide specifically, if you ramp up too quickly you might feel a bit over-stimulated — like you’ve had too much coffee. That settles down after a few weeks.

---

STORAGE

Keep your bottles in the fridge — cold, dry, dark. They’ll easily last 4–6 months once reconstituted. Probably more like 8–12, but you’ll use it well before then.

Unreconstituted powder can be stored at room temperature, but the fridge is always better.